EcoDrugPlus

Ensembl ID : ML343433a
Gene Symbol: -
External references: -
262 Possible Orthologues:

Ensembl ID : ML351729a
Gene Symbol: -
External references: -
153 Possible Orthologues:

Ensembl ID : ML35322a
Gene Symbol: -
External references: -
91 Possible Orthologues:

Ensembl ID : ML35323a
Gene Symbol: -
External references: -
194 Possible Orthologues:

Ensembl ID : ML35324a
Gene Symbol: -
External references: -
194 Possible Orthologues:

Ensembl ID : ML35608a
Gene Symbol: -
External references: -
104 Possible Orthologues:

Ensembl ID : ML35652a
Gene Symbol: -
External references: -
68 Possible Orthologues:

Ensembl ID : ML358815a
Gene Symbol: -
External references: -
97 Possible Orthologues:

Ensembl ID : ML358829a
Gene Symbol: -
External references: -
129 Possible Orthologues:

Ensembl ID : ML35914a
Gene Symbol: -
External references: -
104 Possible Orthologues:

Ensembl ID : ML36894a
Gene Symbol: -
External references: -
68 Possible Orthologues:

Ensembl ID : ML36932a
Gene Symbol: -
External references: -
240 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).